| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Peer Point Medical Education Institute is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amsino International is a Pomona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Resilience training for employers, health plans, and individuals to improve outcomes in stress management, productivity, health, and wellbeing.
Hawaii Primary Care Association is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Honolulu, HI. To find more information about Hawaii Primary Care Association, please visit www.hawaiipca.net